News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
784,002 Results
Type
Article (55715)
Company Profile (395)
Press Release (727866)
Multimedia
Podcasts (205)
Webinars (30)
Section
Business (218263)
Career Advice (2917)
Deals (38238)
Drug Delivery (160)
Drug Development (87407)
Employer Resources (185)
FDA (17823)
Job Trends (16084)
News (372282)
Policy (35867)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2722)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (166)
Alliances (54682)
ALS (204)
Alzheimer's disease (1862)
Antibody-drug conjugate (ADC) (411)
Approvals (18056)
Artificial intelligence (690)
Autoimmune disease (248)
Automation (53)
Bankruptcy (383)
Best Places to Work (11939)
BIOSECURE Act (23)
Biosimilars (219)
Biotechnology (245)
Bladder cancer (185)
Brain cancer (70)
Breast cancer (703)
Cancer (5544)
Cardiovascular disease (488)
Career advice (2481)
Career pathing (46)
CAR-T (329)
CDC (71)
Celiac Disease (1)
Cell therapy (889)
Cervical cancer (42)
Clinical research (74904)
Collaboration (2063)
Company closure (7)
Compensation (1308)
Complete response letters (90)
COVID-19 (2933)
CRISPR (106)
C-suite (1042)
Cystic fibrosis (157)
Data (7156)
Decentralized trials (3)
Denatured (71)
Depression (173)
Dermatology (59)
Diabetes (569)
Diagnostics (7009)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (332)
Drug pricing (237)
Drug shortages (36)
Duchenne muscular dystrophy (286)
Earnings (93229)
Editorial (71)
Employer branding (22)
Employer resources (162)
Events (126640)
Executive appointments (1098)
FDA (21363)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1695)
Gene editing (230)
Generative AI (65)
Gene therapy (730)
GLP-1 (1193)
Government (4775)
Grass and pollen (8)
Guidances (398)
Healthcare (19053)
HIV (79)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (326)
Immuno-oncology (90)
Indications (157)
Infectious disease (3276)
Inflammatory bowel disease (222)
Inflation Reduction Act (17)
Influenza (137)
Intellectual property (282)
Interviews (530)
IPO (17354)
IRA (61)
Job creations (4484)
Job search strategy (2052)
JPM (73)
Kidney cancer (19)
Labor market (100)
Layoffs (655)
Leadership (45)
Legal (8921)
Liver cancer (104)
Longevity (29)
Lung cancer (739)
Lymphoma (413)
Machine learning (54)
Management (63)
Manufacturing (1000)
MASH (194)
Medical device (14318)
Medtech (14395)
Mergers & acquisitions (22068)
Metabolic disorders (1565)
mRNA (210)
Multiple sclerosis (182)
NASH (24)
Neurodegenerative disease (423)
Neuropsychiatric disorders (115)
Neuroscience (3370)
Neurotech (2)
NextGen: Class of 2026 (6923)
Non-profit (4358)
Now hiring (73)
Obesity (775)
Opinion (348)
Ovarian cancer (189)
Pain (243)
Pancreatic cancer (264)
Parkinson's disease (362)
Partnered (35)
Patents (580)
Patient recruitment (616)
Peanut (62)
People (63993)
Pharmaceutical (107)
Pharmacy benefit managers (36)
Phase 1 (23238)
Phase 2 (32758)
Phase 3 (24762)
Pipeline (7277)
Policy (368)
Postmarket research (2913)
Preclinical (9815)
Press Release (70)
Prostate cancer (289)
Psychedelics (61)
Radiopharmaceuticals (326)
Rare diseases (1102)
Real estate (6822)
Recruiting (74)
Regulatory (27454)
Reports (56)
Research institute (2550)
Resumes & cover letters (458)
Rett syndrome (33)
RNA editing (21)
RSV (94)
Schizophrenia (176)
Series A (291)
Series B (214)
Service/supplier (20)
Sickle cell disease (114)
Special edition (29)
Spinal muscular atrophy (180)
Sponsored (51)
Startups (4071)
State (2)
Stomach cancer (21)
Supply chain (128)
Tariffs (102)
The Weekly (131)
Vaccines (1212)
Venture capital (111)
Weight loss (530)
Women's health (113)
Worklife (23)
Date
Today (131)
Last 7 days (686)
Last 30 days (2863)
Last 365 days (31733)
2026 (8429)
2025 (32048)
2024 (36884)
2023 (41668)
2022 (52763)
2021 (57291)
2020 (55713)
2019 (48194)
2018 (36488)
2017 (34978)
2016 (35412)
2015 (41029)
2014 (35597)
2013 (30186)
2012 (32168)
2011 (32479)
2010 (31105)
Location
Africa (955)
Alabama (99)
Alaska (7)
Arizona (355)
Arkansas (14)
Asia (46925)
Australia (7614)
California (12560)
Canada (3533)
China (1323)
Colorado (530)
Connecticut (548)
Delaware (380)
Europe (106347)
Florida (1884)
Georgia (412)
Hawaii (4)
Idaho (69)
Illinois (1027)
India (86)
Indiana (583)
Iowa (22)
Japan (503)
Kansas (132)
Kentucky (48)
Louisiana (38)
Maine (83)
Maryland (1545)
Massachusetts (9149)
Michigan (369)
Minnesota (701)
Mississippi (7)
Missouri (146)
Montana (36)
Nebraska (30)
Nevada (138)
New Hampshire (85)
New Jersey (3379)
New Mexico (31)
New York (3320)
North Carolina (1674)
North Dakota (10)
Northern California (6162)
Ohio (378)
Oklahoma (22)
Oregon (46)
Pennsylvania (2479)
Puerto Rico (27)
Rhode Island (51)
South America (1374)
South Carolina (78)
South Dakota (1)
Southern California (4940)
Tennessee (199)
Texas (1984)
United States (44893)
Utah (358)
Vermont (1)
Virginia (313)
Washington D.C. (86)
Washington State (1010)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
784,002 Results for "biopharma solutions baxter s pharma biotech partnering business".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Pharma Double-Dippers Lead Q1 Deal Activity to Nearly $47B
Deal-hungry Big Pharmas, a long-sought biotech prize, an infrequent buyer and one serial biotech rabblerouser highlight a busy quarter in biopharma M&A.
April 1, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Ulrich Wendt joins UK biotech Alchemab Therapeutics as Chief Business Officer to expand biopharma partnerships
March 17, 2026
·
2 min read
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
April 1, 2026
·
4 min read
Mergers & acquisitions
6 Biotechs That Could Be Big Pharma’s Next M&A Target
Metsera showed the biopharma world that M&A is back. Who could be next?
December 17, 2025
·
8 min read
·
Annalee Armstrong
Insights
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer C. Smith-Parker
Mergers & acquisitions
Pharma Is Ravenous for M&A Action but Late-Stage Supply Dwindles
Whether happening in public or private, biopharma M&A is fiercer than ever. Experts point to patent pressures, herd mentality and a declining stock of available biotechs with mature assets.
March 11, 2026
·
5 min read
·
Annalee Armstrong
Insights
Rethinking Biotech’s Valley of Death as Federal Grants and Family Offices Step In
With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter,” early stage biotechs are rewriting their financing strategies around nondilutive capital and targeted private wealth.
March 4, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Sponsored
What Biopharma Can Learn from Formula 1: Precision, Speed, and the Power of the Right Partner
As the Formula 1 season kicks off in the APAC region, biopharma companies can take a page from the popular sport’s playbook around precision, adaptability, and the right team. In return, biopharma can also offer some lessons to elite motor sport on well-rounded excellence in the race to market.
March 16, 2026
·
5 min read
Press Releases
BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair
March 19, 2026
·
4 min read
1 of 78,401
Next
